Celularity CELU
NASDAQ CELU
$1.38 +0.03 (+2.22%)
At close: Oct 1, 2026 · 4:00 PM EDT

Celularity (CELU) Capital Leases (2020 - 2021)

Updated

Celularity's Capital Leases was $28.09 million in Q4 2021, up 1.6% from $27.63 million a year earlier and up 0.2% from the prior quarter.

Analysis

Celularity (CELU) Capital Leases (2020 - 2021) Analysis & Trends

  • In earlier years, Capital Leases was $27.63 million in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Celularity 39.39 Mn 31.87 Mn 2.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 28.09 Mn
Sep 30, 2021 28.02 Mn
Dec 31, 2020 27.63 Mn
API Access

Celularity Capital Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-leases&ticker=CELU&period=max&api_key=YOUR_API_KEY